Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Publication year range
1.
J Pathol ; 207(2): 232-42, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16052471

ABSTRACT

Smad signalling plays important roles in developmental and cancer biology as well as in fibropathogenesis. Its role in keloid biology is not known. Epithelial-mesenchymal interactions, originally described in normal skin, have recently been established to play a significant role in keloid pathogenesis, and demonstrate the important influence of keratinocyte paracrine factor signalling on fibroblast behaviour. The present study investigated the role of downstream Smad cascade induction in this interaction. Normal fibroblasts (NF) and keloid fibroblasts (KF) were co-cultured in serum-free medium with normal keratinocytes (NK) or keloid keratinocytes (KK) for 5 days, after which fibroblast cell lysates were subjected to western blot and immunoprecipitation analysis to quantify the levels of Smad and Smad2/3/4 binding complex. In another set of experiments, wild-type (wt), Smad2-null (Smad2-/-) and Smad3-null (Smad3-/-) mouse embryonic fibroblasts (MEF) were assayed for cell proliferation and collagen production after serum-free co-culture with KK or exposure to conditioned media collected from serum-free KK/KF co-culture. Compared to normal skin, keloids expressed high basal levels of TGFbetaR1 and TGFbetaR2, Smad2, 3 and 4 and phospho-Smad2. Upregulation of TGFbetaR1 and TGFbetaR2, Smad3 and p-Smad2 was observed in KF co-cultured with KK, together with enhanced Smad3 phosphorylation and Smad2/3/4 binding complex production. When MEF-wt, MEF-Smad2-/- or MEF-Smad3-/- were co-cultured with KK or exposed to KK/KF co-culture conditioned media, enhanced proliferation and collagen production were seen in MEF-wt and MEF-Smad2-/- but not in MEF-Smad3-/- cells. The activation of Smad signalling, importantly that of Smad3, appears to be one facet of the complex epithelial-mesenchymal interactions in keloid pathogenesis, resulting in active KF proliferation and collagen-ECM production in co-culture with KK. This finding suggests the suppression of Smad signalling as a novel approach in keloid therapy.


Subject(s)
DNA-Binding Proteins/analysis , Keloid/metabolism , Signal Transduction/physiology , Trans-Activators/analysis , Adolescent , Adult , Benzamides/pharmacology , Burns/metabolism , Cell Division/drug effects , Child , Cicatrix/metabolism , Coculture Techniques/methods , Collagen Type I/analysis , Collagen Type III/analysis , Dioxoles/pharmacology , Epithelial Cells/metabolism , Female , Fibroblasts/metabolism , Fibronectins/analysis , Humans , Keratinocytes/metabolism , Male , Mesoderm/metabolism , Phosphorylation , Receptors, Transforming Growth Factor beta/analysis , Smad2 Protein , Smad3 Protein , Smad4 Protein
2.
Anal Biochem ; 284(2): 375-81, 2000 Sep 10.
Article in English | MEDLINE | ID: mdl-10964422

ABSTRACT

None of the currently used methods to evaluate bone resorption by osteoclasts cultured on bone substrate measures directly the amounts of degraded bone collagen, which is a direct reflection of the osteoclast "work done." We therefore propose a reliable biochemical method to evaluate the in vitro collagenolysis process. Bone-resorbing activity was evaluated, after HPLC separation, by fluorimetric measurement of hydroxylysylpyridinoline (HP), a collagen cross-link molecule, released in culture supernatants. We first confirm previous data reporting that HP is released in the culture medium in a peptide-conjugated form. After acid hydrolysis, we show that HP is highly correlated with the lacunae area (r = 0.68, P<0.0001) and with the amounts of antigenic collagen fragments (Cross-laps for culture) released in culture medium (r = 0.77, P<0.0002). Using a cysteine protease inhibitor, we observed that lacunae areas are dramatically less inhibited (35% inhibition) than the release of bone-degraded products, including HP and antigenic collagen fragments (96 and 92% inhibition, respectively). Coupled to the resorbed area measurement, biochemical evaluations offer both quantitative and qualitative complementary measurements of the osteoclastic bone-resorbing process.


Subject(s)
Bone Resorption , Chromatography, High Pressure Liquid/methods , Osteoclasts/chemistry , Pyridines/analysis , Animals , Cells, Cultured , Female , Osteoclasts/cytology , Rabbits
3.
Biochem Biophys Res Commun ; 268(3): 899-903, 2000 Feb 24.
Article in English | MEDLINE | ID: mdl-10679302

ABSTRACT

Although the inhibitory effects of high extracellular calcium concentrations ([Ca](e)) on osteoclastic bone resorption have been known for several years, the exact mechanism remains poorly understood. The present study was performed to investigate the possible effect of [Ca](e) on osteoclast apoptosis. Using highly purified rabbit osteoclasts, we have shown that calcium directly promotes apoptosis in a dose-dependent manner which correlates with the dose range of calcium for the inhibition of bone resorption. A time-course experiment of apoptotic changes of osteoclasts cultured in presence of 1.8 or 20 mM calcium showed a significant difference after as early as 8 h of culture. After 72 h of culture, we observed that 80% of the cells cultured in the presence of 20 mM calcium displayed the typical features of apoptosis compared to only 20% in the medium containing 1.8 mM calcium. Calcium channel blockers and ryanodine abrogated the effects of [Ca](e) on apoptosis while neomycin, a calcium-sensing receptor agonist, did not alter cell viability. Taken together, these results suggest that calcium influx is involved in calcium-induced osteoclast apoptosis. Our results are consistent with the concept that in the presence of high [Ca](e) generated during bone demineralization, osteoclasts are subjected to negative-feedback regulation due, at least in part, to the induction of apoptosis.


Subject(s)
Apoptosis/drug effects , Calcium/pharmacology , Osteoclasts/cytology , Osteoclasts/drug effects , Animals , Bone Resorption/metabolism , Bone Resorption/pathology , Calcium/administration & dosage , Calcium/metabolism , Dose-Response Relationship, Drug , Extracellular Space/metabolism , Female , In Vitro Techniques , Osteoclasts/metabolism , Rabbits
4.
C R Acad Sci III ; 323(11): 951-7, 2000 Nov.
Article in French | MEDLINE | ID: mdl-11144027

ABSTRACT

Throughout life, bone is remodelled in a dynamic process which results in a balance between bone formation by osteoblasts and bone resorption by osteoclasts. It is now clearly established that osteoblasts/stromal cells are crucial for differentiation of osteoclasts, through a mechanism involving cell-to-cell contact. However, the possible involvement of osteoblasts and stromal cells in the survival of osteoclasts has not yet been clearly demonstrated. In this study, we assessed the influence of cellular microenvironment, especially osteoblasts, on the osteoclast survival. Our results have shown significant differences in osteoclastic survival between unfractionated bone cells and pure osteoclasts. Furthermore, we have shown that addition of 1.25(OH)2D3 to unfractionated bone cells resulted in a dose-dependent increase in osteoclast survival. Finally, we have shown that a conditioned medium obtained from rat osteoblastic cells cultured with calcitriol was able to increase significantly survival of pure osteoclasts. Taken together, these results strongly suggest that osteoblastic cells present in the bone microenvironment might play a role in the osteoclastic survival by producing soluble factor which modulate osteoclast apoptosis.


Subject(s)
Calcitriol/pharmacology , Osteoblasts/physiology , Osteoclasts/cytology , Osteoclasts/physiology , Animals , Apoptosis , Cell Communication , Cell Differentiation , Cell Survival/drug effects , Cells, Cultured , Coculture Techniques , Kinetics , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoclasts/drug effects , Rabbits , Rats , Stromal Cells/cytology , Stromal Cells/drug effects , Stromal Cells/physiology
SELECTION OF CITATIONS
SEARCH DETAIL